Company profile

Kissei Pharmaceutical

Diversified pharma

4547 · TSE · Japan

Public Market Listing

4547TSE

TSE primary exchange listing

Live quotes, historical charts, and market capitalization for Kissei Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
JR-131No recent activity
Phase 3
Erythropoietin receptor (EPO-R)Biologic — subtype unspecified
Chronic Kidney Disease
Mitiglinide(Glufast)
Phase 3
SUR1 (short-acting)Small molecule
Type 2 Diabetes
KSP-0243
Phase 2
Undisclosed / early pipelineSmall molecule
Inflammatory Bowel Disease
Ulcerative Colitis
Matsupexole (KDT-3594)
Phase 2
D2/D3Small molecule
Parkinson's Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.